Tandem Diabetes Care Inc (FRA:TD5A)
€ 46.5 -0.61 (-1.29%) Market Cap: 3.09 Bil Enterprise Value: 3.10 Bil PE Ratio: 0 PB Ratio: 13.74 GF Score: 78/100

Tandem Diabetes Care Inc at Piper Sandler Ophthalmology and Diabetes Symposium (Virtual) Transcript

May 25, 2022 / 03:00PM GMT
Release Date Price: €60.87 (-7.14%)
Matthew Oliver O;Brien;John F. Sheridan
Piper Sandler & Co., Research Division - MD & Senior Research Analyst;

' -

All right. Good morning, everybody. Thanks for joining us. It's Matt O'Brien from Piper's med-tech research team on here with you. Thanks for joining our Annual Diabetes Day. Really excited to have Tandem Diabetes on with us. From the company, we've got John Sheridan, President and Chief Executive Officer; Liz Gasser, who is Executive Vice President and Chief Strategy Officer; as well as Leigh Vosseller, who is Executive Vice President and Chief Financial Officer; and Susan, who is in the background there as well.

Typical format of the call. I'm going to be asking them some questions. And then, certainly, if you have questions, send them in. There's a Q&A feature at the bottom of the Zoom here. It's that, or just e-mail me at [email protected]. We have about 45 minutes here to run through these questions. So again, if you have them, please do send them over.

Team Tandem, thanks so much for the time this morning.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot